A Study of Immediate 9 Months Adjuvant Hormone Therapy With Triptorelin 11.25 mg Versus Active Surveillance After Radical Prostatectomy in High Risk Prostate Cancer Patients.
Condition: Prostate CancerIntervention: Drug: Triptorelin 11.25 mgSponsor: IpsenRecruiting - verified November 2014
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Hormonal Therapy | Hormones | Prostate Cancer | Research | Study